Top Cannabis Investment News, Member Posts, Cannabis Investment Daily Indices and more!

3yrs ago Cannabis greenmarketreport Views: 357

-

SprinJene and its partner Zelira Therapeutics (ASX: ZLD, OTCQB: ZLDAF) today officially launch their new CBD oral care line. In September, we reported on their partnership announcement and the future launch of their new hemp-derived CBD oral care line. The companies said their product would be available by Q4 of 2020. In a press release the companies announced the first product from its line will be available on Monday, December 7th at SprinJene.com.

-

This new launch already expands upon SprinJene’s premium natural oral care products which are Gluten-Free, Cruelty-Free, Vegan, Kosher, USDA Bio-preferred, and Halal oral care. The New Jersey based company which recently received its first ADA (American Dental Association) seal of acceptance for its Fresh Boost toothpaste. The formula for SprinJene products holds a patented formula of zinc and black seed oil, which together can provide relief from dry mouth, control tartar growth, and deliver long-lasting oral freshness. Black Seed oil and zinc have been shown to fight gingivitis (gum disease) and reduce gum inflammation. Their products are nationwide and can be found in such retails as Costco, Bed Bath & Beyond, and VitaCost and online at Walmart.com and Amazon.

-

Dr. Sayed Ibrahim, CEO of SprinJene said, “Our brand is built on harnessing the power of natural ingredients to protect and improve our oral health, and CBD, with its inherent anti-inflammatory, antibacterial and homeostatic properties are shown to be powerful tools in that fight.”

In its release, the company said research shows that incorporating CBD into oral/dental care results in health benefits such as: naturally eliminating decay-causing bacteria, reducing gum inflammation, restoring pH balance and increasing remineralization, reducing bone loss associated with gum disease, and helping to improve overall health.

SprinJene’s formulation was created with Zelira and uses hemp-derived broad-spectrum, THC-free CBD, unlike other brands that use hemp seed oil with no CBD. With their unique formulation which includes black seed oil as well, consumers will receive the benefits of CBD with no psychoactive “feeling of high” effects.

-

“We are thrilled to enter the national oral care market alongside our remarkable partner. SprinJene shares our values of aligning nature and science,” said Dr. Oludare Odumosu, Zelira’s CEO & Managing Director (USA).  “As you can see SprinJene continues to innovate and with this expansion, consumers will receive the benefits of the effectiveness of CBD and other cannabinoids improving our health from head-to-toe.”

 

SprinJene And Zelira Deliver CBD Oral Care Line on Green Market Report.


Today's Cannabis Investment Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.